Multivariate analysis of development of GVHD and TRM
| . | GVHD OR (95% CI) . | P value . | TRM OR (95% CI) . | P value . |
|---|---|---|---|---|
| Vitamin A level | 3.32 (1.5-6.7) | .003 | 3.07 (0.9-10.1) | .06 |
| Malignancy | 1.9 (1-3.7) | .06 | 1.89 (0.6-5.8) | .27 |
| HLA match | 1.42 (0.5-3.9) | .5 | 1.11 (0.2-6.7) | .9 |
| Stem cell source | ||||
| BM | 1.8 (0.5-6) | .3 | 1.74 (0.2-13.7) | .6 |
| CB | 1.7 (0.1-24.2) | .7 | 3.73 (0.08-164.9) | .5 |
| PBSC | BV | NA | BV | NA |
| . | GVHD OR (95% CI) . | P value . | TRM OR (95% CI) . | P value . |
|---|---|---|---|---|
| Vitamin A level | 3.32 (1.5-6.7) | .003 | 3.07 (0.9-10.1) | .06 |
| Malignancy | 1.9 (1-3.7) | .06 | 1.89 (0.6-5.8) | .27 |
| HLA match | 1.42 (0.5-3.9) | .5 | 1.11 (0.2-6.7) | .9 |
| Stem cell source | ||||
| BM | 1.8 (0.5-6) | .3 | 1.74 (0.2-13.7) | .6 |
| CB | 1.7 (0.1-24.2) | .7 | 3.73 (0.08-164.9) | .5 |
| PBSC | BV | NA | BV | NA |
BV, baseline value; NA, not available.